Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth AXiS™ surgical system, a next-generation platform that ...

The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.

FDA clearance for Stealth AXiS™, PMA approval for Infuse™ TLIF, and a strong Q3 earnings beat set the stage for what ...

Medtronic built the Stealth AXiS system to support a wide range of surgeon preferences, clinical complexity, and care settings.

GALWAY, Ireland - Medtronic (NYSE:MDT) announced today it has received U.S. Food and Drug Administration clearance for its Stealth AXiS surgical system, an integrated platform combining planning, ...

The U.S. Food and Drug Administration classified a software glitch with Medtronic's StealthStation S8 surgical navigation system as a Class I recall, the most serious issued by the agency.